People · Operator
Named in public records as an officer, director or promoter · active 2014–2020 · Pharmaceuticals, Biotechnology, Media & Content, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lycera Corp | — | Pharmaceuticals | Series B | $85.7M | $1.0B | 2015 |
| AbCellera Biologics Inc. | — | Biotechnology | Series C | $83.0M | $3.1B | 2020 |
| Cipher Online Media, Inc. | — | Media & Content | Seed | $4.4M | $50.6M | 2016 |
| Alion Science & Technology Corp | — | Other Technology | Seed | $1.7M | $58.1M | 2014 |
Michael Hayden at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Hayden on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Kristina Burow | 1 | 16 |
| Nina Kjellson | 1 | 11 |
| Stewart Alsop | 1 | 10 |
| PAUL SEKHRI | 1 | 7 |
| John Hamer | 1 | 7 |
| Jeffrey Leiden | 1 | 4 |
| Kathleen M. Metters | 1 | 4 |
| Tim Mayleben | 1 | 4 |
| Michael Steinmetz | 1 | 4 |
| Doug Janzen | 1 | 4 |
| Michael Ryan | 1 | 4 |
| Timothy M. Mayleben | 1 | 4 |
| Robert Kamen | 1 | 3 |
| TIMOTHY MAYLEBEN | 1 | 3 |
| Gary D. Glick | 1 | 3 |
| Carl Hansen | 1 | 2 |
| Kristina Burrow | 1 | 1 |
| Steve M. Gillis | 1 | 1 |
| Robert M. Kamen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.